Beranda › Karsinoma Nasofaring › Missouri
Uji klinis Karsinoma Nasofaring di Missouri
3 studi untuk Karsinoma Nasofaring mencari peserta di lokasi di Missouri.
Teks studi resmi (Bahasa Inggris)
Testing the Addition of BMS-986016 (Relatlimab) to the Usual Immunotherapy After Initial Treatment for Recurrent or Metastatic Nasopharyngeal Cancer
- Mercy Hospital South, St Louis
- Mercy Hospital Saint Louis, St Louis
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 16 Sep 2026 · NCT06029270A Study Using Nivolumab, in Combination With Chemotherapy Drugs to Treat Nasopharyngeal Carcinoma (NPC)
- Children's Mercy Hospitals and Clinics, Kansas City
- Washington University School of Medicine, St Louis
Menerima pesertaFase 2
Hingga usia 21 · Semua jenis kelamin · Diperbarui 14 Sep 2026 · NCT06064097Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer
- Saint Francis Medical Center, Cape Girardeau
- Lake Regional Hospital, Osage Beach
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 17 Agu 2026 · NCT06532279Dari ClinicalTrials.gov, data diambil 6 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.